When multiple papers from a single study had been published, we used the latest publication and supplemented it with data from the earlier publication(s)
GLP-1 receptor agonists in heart failure GLP-1 receptor agonists have demonstrated favorable cardiovascular effects in patients with T2DM and obesity as meta-analyses suggest a reduction in hospitalization for incident or new-onset HF of approximately 18%, alongside reductions in major adverse cardiovascular events [6, 14, 15]
Pilar Schiavo Legislator So I just think this is a very smart investment, for us to make as a state and, again, the care, you know, being quality too
Nalivaeva, N
However, in individuals with type 2 diabetes, infusions of GIP(3-30)NH 2 reduced glucagon concentrations (78), illustrating the potential of GIP receptor antagonism to limit the paradoxical postprandial hyperglucagonemia in individuals with type 2 diabetes (93)
It can also interrupt sleep, creating a vicious stress/sleeplessness cycle